Clinical Trial: Plasma exchange combined with Ofatumumab in the treatment of optic neuromyelitis spectrum diseases, a multicenter randomized controlled study (China)

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Plasma exchange combined with Ofatumumab in the treatment of optic neuromyelitis spectrum diseases, a multicenter randomized controlled study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130207

Registration Time: 2026/08/17

Type: Interventional study

Primary Sponsor: Renji Hospital, School of Medicine, Shanghai Jiao Tong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323506

Published by HT Digital Content Services with permission from Health Daily Digest....